Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Sangamo Therapeutics revenue
Sangamo Therapeutics's revenue is $57.8 million.
What is Sangamo Therapeutics's revenue?
- Sangamo Therapeutics's revenue growth from 2010 to 2024 is 177.82%.
- Sangamo Therapeutics has 354 employees, and the revenue per employee ratio is $163,276.
- Sangamo Therapeutics's peak quarterly revenue was $158.0M in 2023(q1).
- Sangamo Therapeutics peak revenue was $176.2M in 2023.
- Sangamo Therapeutics annual revenue for 2023 was 176.2M, 58.34% growth from 2022.
- Sangamo Therapeutics annual revenue for 2024 was 57.8M, -67.2% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Sangamo Therapeutics historical revenue
Sangamo Therapeutics's peak revenue was $176.2M in 2023. The peak quarterly revenue was $158.0M in 2023(q1).
Sangamo Therapeutics's revenue increased from $20.8m in 2010 to $57.8M currently. That's a 177.82% change in annual revenue.
Sangamo Therapeutics annual revenue
Sangamo Therapeutics annual revenue over time
| Fiscal year / year | Sangamo Therapeutics revenue |
|---|---|
| 2010 | $20.8M |
| 2011 | $10.3M |
| 2012 | $21.7M |
| 2013 | $24.1M |
| 2014 | $45.9M |
| 2015 | $39.5M |
| 2016 | $19.4M |
| 2017 | $36.6M |
| 2018 | $84.5M |
| 2019 | $102.4M |
| 2020 | $118.2M |
| 2021 | $110.7M |
| 2022 | $111.3M |
| 2023 | $176.2M |
| 2024 | $57.8M |
Rate Sangamo Therapeutics' financial transparency
Sangamo Therapeutics annual growth
Sangamo Therapeutics saw the greatest revenue growth in 2018, when revenue increased by 130.95%.
Sangamo Therapeutics had the lowest revenue growth in 2016, when revenue changed by -50.96%.
Sangamo Therapeutics annual growth rate over time
| Year | Sangamo Therapeutics growth |
|---|---|
| 2011 | -50%↓ |
| 2012 | 110%↑ |
| 2013 | 11%↑ |
| 2014 | 90%↑ |
| 2015 | -14%↓ |
| 2016 | -51%↓ |
| 2017 | 89%↑ |
| 2018 | 131%↑ |
| 2019 | 21%↑ |
| 2020 | 15%↑ |
| 2021 | -6%↓ |
| 2022 | 1%↑ |
| 2023 | 58%↑ |
| 2024 | -67%↓ |
Sangamo Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Sangamo Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2011 | - | $1.5M | $1.9M | $4.7M |
| 2012 | $3.2M | $4.6M | $4.9M | $8.9M |
| 2013 | $4.6M | $6.9M | $5.7M | $6.9M |
| 2014 | $8.1M | $10.4M | $12.4M | $15.0M |
| 2015 | $13.5M | $8.4M | $8.6M | $9.1M |
| 2016 | $3.9M | $3.7M | $2.8M | $8.9M |
| 2017 | $3.4M | $8.3M | $11.8M | $13.1M |
| 2018 | $12.6M | $21.4M | $23.6M | $26.8M |
| 2019 | $8.1M | $17.5M | $22.0M | $54.9M |
| 2020 | $13.1M | $21.6M | $57.8M | $25.8M |
| 2021 | $26.3M | $27.9M | $28.6M | $28.0M |
| 2022 | $28.2M | $29.4M | $26.5M | $27.2M |
| 2023 | $158.0M | $6.8M | $9.4M | $2.0M |
| 2024 | $481,000 | $356,000 | $49.4M | $7.6M |
Sangamo Therapeutics jobs nearby
Do you work at Sangamo Therapeutics?
Did Sangamo Therapeutics meet its revenue projections?
Sangamo Therapeutics financial information
| CEO | Alexander D. MacRae |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 354 |
| Date Founded | 1995 |
| Headquarters | Richmond, California |
| Number of Locations | 2 |
| Revenue | $57.8M |
| Net Income | -$192,278,000 |
| PE Ratio | -11.44 |
| Tax Rate | 0.0% |
| Market Capitalization | $1.1B |
| Total Assets | $562,509,000 |
| Ticker | SGMO |
Sangamo Therapeutics jobs you might like
Sangamo Therapeutics financing
Sangamo Therapeutics received early financing of $74.2M on 2013-09-24.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $74.2M | 09/2013 |
| Post Ipo Equity | $83.4M | 06/2017 |
| Grant | $11M | 02/2018 |
| Post Ipo Equity | $200M | 04/2018 |
| Grant | $8M | 04/2018 |
| Post Ipo Equity | $145.5M | 04/2019 |
Sangamo Therapeutics investors
| Investors | Security type |
|---|---|
| National Institutes of Health (NIH) | Grant |
| California Institute for Regenerative Medicine | Grant |
Search for jobs
Sangamo Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Sangamo Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sangamo Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sangamo Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sangamo Therapeutics. The data presented on this page does not represent the view of Sangamo Therapeutics and its employees or that of Zippia.
Sangamo Therapeutics may also be known as or be related to SANGAMO THERAPEUTICS INC, Sangamo Therapeutics, Sangamo Therapeutics Inc and Sangamo Therapeutics, Inc.